PepGen Eulerpool News

PepGen Stock News

PepGen is being monitored by journalists and investors worldwide. We gather the latest PepGen news here.

PepGen Stock Press Releases

PepGen regularly publishes news on the company's website that are relevant for investors.

PepGen News 2026

This page contains all current news, analysis and press releases for PepGen stock (PEPG, ISIN: US7133171055). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at PepGen.

PepGen Stock

PepGen PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees.